IDYAIDEAYA Biosciences, Inc.
$34.68+25% 1Y
$34.68
$27.6052 weeks$42.48
Is the price fair?
What IDYA's price assumes
IDEAYA Biosciences, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 14.3× revenue.
14.3
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.79
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 11.6
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.79
- EV / EBIToperating margin −93%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 11.6
- Market capitalisation96.5 million shares, counted Jul 31, 2026
- $3.35B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.